Thursday, January 9, 2014

A Model of HIV Drug Resistance Published in BMC Systems Biology Journal

A Model of HIV Drug Resistance Driven by Heterogeneities in Host Immunity and Adherence Patterns explores methods of implementing host heterogeneities and their long-term effects on drug resistance using the example of accidental tenofovir-based pre-exposure prophyaxis (PrEP) use during HIV infection.